PI

Progress in Cardiovascular Diseases

Progress in Cardiovascular Diseases comprehensively covers a single topic in each issue related to the understanding and treatment of disorders of the heart and circulation. Some issues include special articles and definitive reviews that capture the state of the art in the management of particular clinical problems in cardiology.

Looking to publish in Progress in Cardiovascular Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Cardiac & Cardiovascular Systems
Impact Factor 7.6
Quartile Q1
Open Access Type Hybrid
ISSN 0033-0620
eISSN 1873-1740
Invitation Only No
Cost Range USD 4030 APC for all articles published open access, excluding taxes.

Submission Instructions

Progress in Cardiovascular Diseases accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter For clinical trial Research Articles, the cover letter must include an explanation of the clinical trial if the trial name, registry URL, and registration number are not provided in the methods section.
Abstract Research Articles must include an abstract. Abstract must be 250 words or less.
Manuscript Research Articles must be 4,000 words or less. The manuscript must be divided into clearly defined sections using headings. Research Articles must include 3–5 highlights and any use of generative AI in manuscript preparation must be declared in a section placed before the references list.
References Research Articles can include up to 40 references. References must be cited as numbers in square brackets and listed in the order they appear in the article.
Figures & Tables Research Articles can include up to 7 figures. Figures must be uploaded as separate files, while table placement is not explicitly stated. Tables must be submitted as editable text rather than images.
Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Review Articles. Abstract must be 300 words or less.
Manuscript Manuscript must be 5,000 words or less. Manuscript must be divided into clearly defined sections using headings. Manuscript must include 3 to 5 highlights and any use of generative AI in manuscript preparation must be declared in a new section before the references list.
References References must be cited using numbered square-bracket citations. References must be numbered in the order they appear in the article and journal names must be abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Figures must be supplied as separate files and tables must be submitted as editable text. All figures and tables must be cited in the manuscript text, numbered consecutively, and include captions.
Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Viewpoints

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must be 1,200 words or less. Manuscript must be divided into clearly defined sections using headings. The corresponding author’s image must be included upon submission, and any use of generative AI in manuscript preparation must be declared in a section placed before the references list.
References References are limited to 10. References must be cited using numbers in square brackets and numbered in the order they appear in the article.
Figures & Tables A maximum of 1 figure is allowed. Figures must be uploaded separately from the manuscript. Tables must be submitted as editable text rather than images, and each figure or table must be cited in the manuscript and numbered consecutively.
Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Editorials

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must be 1,200 words or less. A declaration of any use of generative AI in manuscript preparation must be included in a new section before the references list at initial submission.
References Reference list may include up to 10 references. References must be cited in the text using numbers in square brackets and listed in the order they appear in the article.
Figures & Tables Submission may include up to 1 figure. Figures must be supplied as separate files rather than embedded only in the manuscript. Tables must be submitted as editable text and each figure and table must be cited in the manuscript text and numbered consecutively in order of appearance.
Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Recent Publications

Lifetime management of valvular heart disease in younger and low risk patients

Laura Novelli, Nerea Fernández Ortiz, Guillem Murillo Varona, José Luis Diez Gil, Jorge Sanz Sanchez

10.1016/j.pcad.2026.10.006
View Publication

Epicardial adipose tissue phenotyping by cardiac CT in heart failure

G. Mendieta, D. Viladés, R. Leta

10.1016/j.pcad.2026.10.002
View Publication

Factors affecting serum neurofilament light chain in transthyretin amyloid cardiomyopathy

Bryton Davis, Yuanzi Zhao, Israt Jahan, Hailey Volk, Nizar Chahin, Ahmad Masri

10.1016/j.pcad.2026.10.004
View Publication

A nonexercise equation to predict VO2 peak in chronic heart failure: Integrating clinical variables for prognostic assessment

Audrey Borghi-Silva, Aldair Darlan Santos-de-Araújo, Samuel Montalvo, Jeffrey W. Christle, Jonathan Myers

10.1016/j.pcad.2026.10.001
View Publication

Hypertension and clinical outcomes following thoracic radiotherapy

Megan McCrohan, Prem Patel, Tyren Busby, Sanam Ghazi, Adia Holtman, Anna Siefker, Elizabeth Wade, Akash Goyal, Eric McLaughlin, Ning Jin, Robert E. Merritt, Dayssy Diaz, Mussammat Ferdousi, Patrick Ruz, Sohil Reddy, Trudy Wu, Dominic DiCostanzo, Austin M. Faught, Jonathan Brammer, Evans Osuji, Onaopepo Kola-Kehinde, Terence M. Williams, Meng Welliver, Eric D. Miller, Daniel Addison

10.1016/j.pcad.2026.10.003
View Publication

Frequently asked questions

How long does it take to publish?

5 days from submission to first decision; 31 days from submission to decision after review; 4 days from submission to acceptance; 3 days from acceptance to online publication.

Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Is a cover letter required?

A clinical trial manuscript must include the trial name, registry URL, and trial registration number in the methods section or the cover letter must include an explanation of the clinical trial.

Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

What are the publication costs?

USD 4030 APC for open access publication, excluding taxes. Subscription publication has no open access publication fee.

Reformat to Progress in Cardiovascular Diseases using Livewrite Premium

Research Topics

Cardiac electrophysiology and arrhythmias Cardiac Imaging and Diagnostics Cardiovascular Function and Risk Factors Diverse Scientific and Economic Studies Cardiac Valve Diseases and Treatments Cardiac Arrhythmias and Treatments Cardiac pacing and defibrillation studies Human auditory perception and evaluation Cardiovascular and exercise physiology Heart Rate Variability and Autonomic Control Heart Failure Treatment and Management Cardiovascular Effects of Exercise Atrial Fibrillation Management and Outcomes Cardiac Structural Anomalies and Repair Acute Myocardial Infarction Research Blood Pressure and Hypertension Studies Coronary Interventions and Diagnostics Educational Robotics and Engineering Cardiomyopathy and Myosin Studies Infective Endocarditis Diagnosis and Management Cardiac Health and Mental Health Congenital Heart Disease Studies Lipoproteins and Cardiovascular Health Ferroelectric and Negative Capacitance Devices Physical Activity and Health

Related Journals

CA
Cognitive and Behavioral Practice Elsevier BV
GO
Gynecologic Oncology Elsevier BV
RA
Radiotherapy and Oncology Elsevier BV
BA
Biomedical and Environmental Sciences Elsevier BV
SR
Schizophrenia Research Elsevier BV
CH
Current Heart Failure Reports Springer Science+Business Media